Nebius: A Pre-Earnings Rally Collides With the Hard Math of Building AI's Backbone

Nebius jumps on $1B AI contract and strong demand, but Q2 earnings and $20-25B capex raise questions on profitability.

The stock market has a way of rewarding conviction stories right before they face their toughest test. Nebius shares jumped 9.47 percent to 182.82 euros on the eve of its second-quarter earnings release, a sharp move that underscores just how much faith investors are placing in the "neocloud" thesis — the idea that specialized, AI-native infrastructure providers can outmaneuver the legacy tech giants in the race to supply computing power for generative AI.

That surge, however, came on top of an already volatile stretch. The stock had pulled back roughly 30 percent from its June peak of 261 euros, and the recent bounce looks less like a decisive reversal than a tentative first step toward recovery. The 4.52 percent gain registered on Tuesday, when shares closed at 166.96 euros, added further momentum — though that move was tied to a specific catalyst.

A Billion-Dollar Contract Enters the Narrative

That catalyst was the confirmation of a multi-year agreement with Reflection AI, a startup focused on open-source AI models. Under the deal, which runs through 2029, Nebius will provide more than $1 billion in computing capacity, including access to Nvidia's GB300 chips. The contract was first announced in mid-July but received fresh confirmation on Tuesday, prompting the market's positive response.

The timing is fortuitous. Nebius is tapping into the same demand wave that has lifted competitor CoreWeave, which recently reported doubled revenue and a $104 billion order backlog. For investors, that signal carries direct implications for Nebius, which is chasing the same surging appetite for AI data centers.

The broader environment is also cooperating. Nvidia's recently unveiled $500 billion financing plan for AI infrastructure is aimed squarely at companies like Nebius, and the chipmaker already holds a $2 billion stake in the company. Add a $27 billion contract from Meta, and these two partnerships alone underpin a substantial portion of Nebius's current market capitalization of 40.5 billion euros.

The Capex Question Looms Large

The real challenge, though, is whether Nebius can convert its massive spending into revenue. The company has raised its annual investment target to $20–25 billion, funds earmarked for sprawling "AI factories" — including a 1.2-gigawatt facility in Pennsylvania and additional sites in Finland.

Wall Street wants proof that these investments are producing results. For the second quarter, analysts expect revenue of roughly $570 million — a figure that represents a dramatic jump from the year-ago period — alongside an adjusted loss of about $0.72 per share. The consensus estimate from the secondary source puts the figure slightly higher at $573 million, implying growth of approximately 446 percent year over year.

More critical than the quarterly print itself is the full-year guidance. Nebius is targeting an annualized recurring revenue (ARR) of $7–9 billion by year-end, and whether that target remains within reach will likely determine whether the stock can reclaim its summer highs or faces further consolidation.

A Stock That Divides Opinion

Despite a 148.73 percent gain since the start of the year, Nebius remains a deeply contested stock. Goldman Sachs maintains its "Buy" rating with a price target of $286, citing the company's "full-stack" advantage — its development of proprietary orchestration and storage technology rather than relying on purchased components.

Others have grown more cautious. Technical delays at the Vineland site prompted DA Davidson to cut its price target to $175. Prominent short sellers, including Michael Burry, are reportedly positioned against the stock, and insider activity tells a similar story: over the past three months, executives have sold shares worth more than $137 million.

The stock's annualized volatility of 148 percent makes it unsuitable for the faint-hearted. Trading 45.67 percent above its 200-day average of 125.50 euros, the shares already reflect considerable optimism — in an industry where construction delays are more the rule than the exception.

Financing, Leadership, and the Road Ahead

The recent pullback has also been fueled by concerns about the company's capital requirements. In May, Nebius raised its 2026 capex target from $16–20 billion to $20–25 billion, alongside securing 1.2 gigawatts of power and site capacity in Pennsylvania. Late July brought another piece of the financing puzzle: a secured credit facility of roughly $775 million, backed by installed GPU infrastructure and existing cash-flow contracts, intended to fund the expansion of the AI cloud business.

There has been a leadership change as well. In early August, Nebius appointed Lindsey Irvine as its new Chief Marketing Officer. Irvine joins from Square, where she oversaw global marketing for more than 4.5 million merchants, and previously served as CMO at Benchling and MuleSoft, where recurring annual revenue grew from $250 million to over $1 billion during her tenure.

The first-quarter results, released in May, offered a glimpse of the company's trajectory: revenue surged to $399 million, up 684 percent year over year, with positive adjusted EBITDA of $129.5 million. The net result of $621.2 million included a non-cash valuation gain, while the adjusted net loss stood at $100.3 million. For the full year, Nebius reaffirmed revenue guidance of $3.0–3.4 billion with an adjusted EBITDA margin of roughly 40 percent — benchmarks against which today's numbers will inevitably be measured.

With the stock still trading 36.03 percent below its 52-week high of 261.00 euros and 13.56 percent beneath its 50-day average of 193.16 euros, the near-term trend remains uncertain. The seven-day decline of 11.78 percent and 30-day drop of 9.70 percent suggest that the recent bounce has yet to break the medium-term downward pattern.

Today's report will show whether Nebius can validate its ARR outlook and demonstrate tangible progress on capacity in Pennsylvania and Finland. If it does, the recovery from June's lows may have room to run. If revenue falls short of the roughly $570 million expectation, the question of whether billion-dollar investments can keep pace with the stock's already ambitious valuation will move back to center stage.